Medpace beats, sets guidance

 

Medpace beats Q2 estimates with non-GAAP EPS $4.25 (+37% YoY), revenue $707.3M (+17% YoY), issues 2026 guidance

• Company guides 2026 GAAP EPS to $17.25–$17.95 and revenue to $2.805–$2.885B.
• Q2 2026 GAAP EPS reported at $4.25, alongside non-GAAP EPS figure of $4.25.

https://finviz.com/stock?t=MEDP&p=d